{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-347839","form_type":"8-K","ticker":"AVAH","cik":"0001832332","company_name":"Aveanna Healthcare Holdings, Inc.","filed_at":"2026-08-13T11:00:19+00:00","discovered_at":"2026-08-13T11:05:00.607698+00:00","generated_at":"2026-08-13T11:05:41.248768+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Aveanna Q2 revenue up 13.7% to $670.5M; raises FY2026 guidance","bullets":["Q2 revenue $670.5M (+13.7% YoY); net income $40.3M vs $27.0M; diluted EPS $0.18 vs $0.13.","Adjusted EBITDA $95.4M (+8.0% YoY); adjusted EPS $0.22 vs $0.18.","FY2026 revenue guidance raised to >$2.68B (from $2.63-2.65B); Adjusted EBITDA >$365M (from $338-342M).","Segment revenue growth: PDS +$67.9M, HHH +$8.9M, MS +$4.1M; gross margin fell to 32.6% from 35.8%."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-347839","json":"https://secwatch.observer/filing/0001193125-26-347839.json","markdown":"https://secwatch.observer/filing/0001193125-26-347839.md","text":"https://secwatch.observer/filing/0001193125-26-347839.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832332/000119312526347839/0001193125-26-347839-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832332/000119312526347839/avah-20260319.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-13T11:05:41.248768+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}